Cliff Asness's CHE Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 415,612 shares of Chemed Corporation (CHE) worth $156.99 M, representing 0.07% of the portfolio. First purchased in 2012-Q4, this long-term strategic position has been held for 54 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in CHE, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2025, adding 153,469 shares. Largest reduction occurred in Q4 2013, reducing 133,989 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Chemed Corporation (CHE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Chemed Corporation (CHE) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +90,033 | Add 27.65% | 415,612 | $377.74 |
| Q4 2025 | +153,469 | Add 89.17% | 325,579 | $427.86 |
| Q3 2025 | -28,931 | Reduce 14.39% | 172,110 | $447.74 |
| Q2 2025 | +123,982 | Add 160.89% | 201,041 | $486.93 |
| Q1 2025 | -3,606 | Reduce 4.47% | 77,059 | $607.45 |
| Q4 2024 | +12,300 | Add 17.99% | 80,665 | $529.80 |
| Q3 2024 | +16,274 | Add 31.24% | 68,365 | $598.41 |
| Q2 2024 | -1,789 | Reduce 3.32% | 52,091 | $542.58 |
| Q1 2024 | -7,197 | Reduce 11.78% | 53,880 | $641.93 |
| Q4 2023 | -3,583 | Reduce 5.54% | 61,077 | $582.00 |
| Q3 2023 | +3,927 | Add 6.47% | 64,660 | $519.70 |
| Q2 2023 | +6,370 | Add 11.72% | 60,733 | $536.58 |
| Q1 2023 | +629 | Add 1.17% | 54,363 | $531.36 |
| Q4 2022 | +6,096 | Add 12.80% | 53,734 | $510.43 |
| Q3 2022 | +348 | Add 0.74% | 47,638 | $436.56 |
| Q2 2022 | -5,168 | Reduce 9.85% | 47,290 | $469.38 |
| Q1 2022 | -9,819 | Reduce 15.77% | 52,458 | $506.56 |
| Q4 2021 | -7,741 | Reduce 11.06% | 62,277 | $529.04 |
| Q3 2021 | +4,697 | Add 7.19% | 70,018 | $465.12 |
| Q2 2021 | +5,937 | Add 10.00% | 65,321 | $474.50 |
| Q1 2021 | +6,981 | Add 13.32% | 59,384 | $459.82 |
| Q4 2020 | +11,313 | Add 27.53% | 52,403 | $524.91 |
| Q3 2020 | +3,875 | Add 10.41% | 41,090 | $480.14 |
| Q2 2020 | -288 | Reduce 0.77% | 37,215 | $440.52 |
| Q1 2020 | +3,008 | Add 8.72% | 37,503 | $431.57 |
| Q4 2019 | -926 | Reduce 2.61% | 34,495 | $439.25 |
| Q3 2019 | -18,338 | Reduce 34.11% | 35,421 | $417.58 |
| Q2 2019 | +2,459 | Add 4.79% | 53,759 | $360.83 |
| Q1 2019 | -11,579 | Reduce 18.41% | 51,300 | $320.08 |
| Q4 2018 | +15,236 | Add 31.98% | 62,879 | $283.27 |
| Q3 2018 | +36,012 | Add 309.62% | 47,643 | $319.59 |
| Q2 2018 | -7,527 | Reduce 39.29% | 11,631 | $321.81 |
| Q1 2018 | +277 | Add 1.47% | 19,158 | $272.84 |
| Q4 2017 | +1,417 | Add 8.11% | 18,881 | $243.00 |
| Q3 2017 | +1,549 | Add 9.73% | 17,464 | $202.07 |
| Q2 2017 | -599 | Reduce 3.63% | 15,915 | $204.52 |
| Q1 2017 | +1,576 | Add 10.55% | 16,514 | $182.69 |
| Q4 2016 | -2,539 | Reduce 14.53% | 14,938 | $160.40 |
| Q3 2016 | -6,646 | Reduce 27.55% | 17,477 | $141.04 |
| Q2 2016 | -2,584 | Reduce 9.68% | 24,123 | $136.30 |
| Q1 2016 | +10,439 | Add 64.17% | 26,707 | $135.43 |
| Q4 2015 | +874 | Add 5.68% | 16,268 | $149.80 |
| Q3 2015 | -2,658 | Reduce 14.72% | 15,394 | $133.49 |
| Q2 2015 | +213 | Add 1.19% | 18,052 | $131.12 |
| Q1 2015 | +1,239 | Add 7.46% | 17,839 | $119.40 |
| Q4 2014 | -3,151 | Reduce 15.95% | 16,600 | $105.66 |
| Q3 2014 | -17,445 | Reduce 46.90% | 19,751 | $102.88 |
| Q2 2014 | +30,396 | Add 447.00% | 37,196 | $93.72 |
| Q1 2014 | -3,000 | Reduce 30.61% | 6,800 | $89.41 |
| Q4 2013 | -133,989 | Reduce 93.18% | 9,800 | $76.63 |
| Q3 2013 | -103,751 | Reduce 41.91% | 143,789 | $71.50 |
| Q2 2013 | +247,540 | Add 0.00% | 247,540 | $72.43 |
| Q4 2012 | +296,300 | Add 0.00% | 296,300 | $68.59 |
Cliff Asness's Chemed Corporation Investment FAQs
Cliff Asness first purchased Chemed Corporation (CHE) in Q4 2012, acquiring 296,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Chemed Corporation (CHE) for 54 quarters since Q4 2012.
Cliff Asness's largest addition to Chemed Corporation (CHE) was in Q4 2012, adding 296,300 shares worth $20.32 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 415,612 shares of Chemed Corporation (CHE), valued at approximately $156.99 M.
As of the Q1 2026 filing, Chemed Corporation (CHE) represents approximately 0.07% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Chemed Corporation (CHE) was 415,612 shares, as reported at the end of Q1 2026.